LNSR - LENSAR, Inc. Stock Price, Fair Value and News

$7.70+0.20 (+2.67%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LNSR Price Action

Last 7 days

2.0%

Last 30 days

5.8%

Last 90 days

73.0%

Trailing 12 Months

174.0%

LNSR RSI Chart

LNSR Valuation

Market Cap

89.4M

Price/Earnings (Trailing)

-5.38

Price/Sales (Trailing)

1.83

Price/Free Cashflow

-13.53

LNSR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LNSR Fundamentals

LNSR Revenue

Revenue (TTM)

48.9M

Rev. Growth (Yr)

38.22%

Rev. Growth (Qtr)

7.15%

LNSR Earnings

Earnings (TTM)

-16.6M

Earnings Growth (Yr)

-158.49%

Earnings Growth (Qtr)

83.39%

LNSR Profitability

Operating Margin

48.89%

Return on Equity

-73.13%

Return on Assets

-26.81%

Free Cashflow Yield

-7.39%

LNSR Investor Care

Shares Dilution (1Y)

3.26%

Diluted EPS (TTM)

-1.22

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	44.5M	45.1M	48.9M	0
2023	34.3M	38.2M	40.3M	42.2M
2022	36.8M	36.9M	36.3M	35.4M
2021	27.5M	30.4M	31.5M	34.5M
2020	29.5M	28.5M	27.4M	26.4M
2019	0	0	0	30.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

CEO	Mr. Nicholas T. Curtis
WEBSITE	lensar.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	110

LENSAR, Inc. Frequently Asked Questions

What is the ticker symbol for LENSAR, Inc.? What does LNSR stand for in stocks?

LNSR is the stock ticker symbol of LENSAR, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of LENSAR, Inc. (LNSR)?

As of Fri Dec 20 2024, market cap of LENSAR, Inc. is 89.43 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNSR stock?

You can check LNSR's fair value in chart for subscribers.

Is LENSAR, Inc. a good stock to buy?

The fair value guage provides a quick view whether LNSR is over valued or under valued. Whether LENSAR, Inc. is cheap or expensive depends on the assumptions which impact LENSAR, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNSR.

What is LENSAR, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, LNSR's PE ratio (Price to Earnings) is -5.38 and Price to Sales (PS) ratio is 1.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNSR PE ratio will change depending on the future growth rate expectations of investors.